Berylson Capital Partners’s Cardlytics CDLX Stock Holding History
Bought
Maintained
Sold
Other funds holding CDLX
CIP
6CM
KGAMU
WPM
BCM
Berylson Capital Partners's CDLX Position: Q3 2024 in Review
Berylson Capital Partners sold out of Cardlytics (CDLX) in Q3 2024, closing a stake of 24,550 shares — an estimated $2.02M sold.
Berylson Capital Partners first reported a position in CDLX in Q1 2020 and held it in 15 quarters. The position peaked at $23M in Q4 2020. 111 funds tracked by Wall St. Rank hold CDLX as of Q3 2024.
- Berylson Capital Partners reported no remaining Cardlytics position as of Q3 2024 after selling out during the quarter.
- Berylson Capital Partners sold 24,550 Cardlytics shares in Q3 2024, an estimated $2.02M.
- Berylson Capital Partners first reported a position in Cardlytics in Q1 2020 and held it in 15 quarters.
- Berylson Capital Partners's Cardlytics position peaked at $23M in Q4 2020.
- 111 funds tracked by Wall St. Rank held Cardlytics as of Q3 2024.
Based on Berylson Capital Partners's 13F filing for Q3 2024, filed 14 Nov 2024.